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Abstract
Background: Intracranial bleeding (IB) is a common and serious consequence of traumatic brain injury (TBI). IB can be
classified according to the location into: epidural haemorrhage (EDH) subdural haemorrhage (SDH) intraparenchymal
haemorrhage (IPH) and subarachnoid haemorrhage (SAH). Studies involving repeated CT scanning of TBI patients have
found that IB can develop or expand in the 48 hours after injury. If IB enlarges after hospital admission and larger bleeds
have a worse prognosis, this would provide a therapeutic rationale for treatments to prevent increase in the extent of
bleeding. We analysed data from the Trauma Audit & Research Network (TARN), a large European trauma registry, to
evaluate the association between the size of IB and mortality in patients with TBI.
Methods: We analysed 13,962 patients presenting to TARN participating hospitals between 2001 and 2008 with a
Glasgow Coma Score (GCS) less than 15 at presentation or any head injury with Abbreviated Injury Scale (AIS) severity
code 3 and above. The extent of intracranial bleeding was determined by the AIS code. Potential confounders were age,
presenting Glasgow Coma Score, mechanism of injury, presence and nature of other brain injuries, and presence of extra-
cranial injuries. The outcomes were in-hospital mortality and haematoma evacuation. We conducted a multivariable
logistic regression analysis to evaluate the independent effect of large and small size of IB, in comparison with no bleeding,
on patient outcomes. We also conducted a multivariable logistic regression analysis to assess the independent effect on
mortality of large IB in comparison with small IB.
Results: Almost 46% of patients had at some type of IB. Subdural haemorrhages were present in 30% of the patients,
with epidural and intraparenchymal present in approximately 22% each. After adjusting for potential confounders, we
found that large IB, wherever located, was associated with increased mortality in comparison with no bleeding. We also
found that large IB was associated with an increased risk of mortality in comparison with small IB. The odds ratio for
mortality for large SDH, IPH and EDH, in comparison with small bleeds, were: 3.41 (95% CI: 2.684.33), 3.47 (95% CI:
2.265.33) and 2.86 (95% CI: 1.864.38) respectively.
Conclusion: Large EDH, SDH and IPH are associated with a substantially higher probability of hospital mortality in
comparison with small IB. However, the limitations of our data, such as the large proportion of missing data and lack of
data on other confounding factors, such as localization of the bleeding, make the results of this report only explanatory.
Future studies should also evaluate the effect of IB size on functional outcomes.
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Background
Intracranial bleeding (IB) is a common and serious conse-
quence of traumatic brain injury (TBI). In the MRC
CRASH trial, which included mild, moderate and severe
TBI patients, 56% of trial participants had at least one IB.
[1] The frequency of IB varies with TBI severity, age, pres-
ence or absence of compound skull fracture, and the ana-
tomical site of injury (frontal, temporo-parietal,
occipital). [2] IB can be classified according to the loca-
tion into epidural haemorrhage (EDH) subdural haemor-
rhage (SDH) intraparenchymal haemorrhage (IPH) and
subarachnoid haemorrhage (SAH).
A review by the Brain Trauma Foundation found that all
types of IB are associated with a worse prognosis, with
increased in-hospital mortality and disability at six
months. [3] Analysis of data from the CRASH trial showed
that subarachnoid bleeding and non evacuated hae-
matoma were independently associated with a worse out-
come at 2 weeks and 6 months. [4] Similarly, the IMPACT
study found that after controlling for age, Glasgow Coma
Score (GCS) motor score and pupil reactions, subarach-
noid and subdural bleeding doubled the odds of poor
outcome at six months. [5]
Some studies involving repeated CT scanning of patients
with TBI have found that intracranial bleeding can
develop or expand in the 2448 hours after injury. These
findings have generated interest in potential therapeutic
approaches, such as haemostatic drugs, that could prevent
or decrease the growth of IB. [6]
If IB enlarges after hospital admission and larger bleeds
have a worse prognosis, this would strengthen the thera-
peutic rationale for agents to prevent an increase in the
extent of bleeding. Although there have been some studies
on the association between size of IB and prognosis, the
empirical evidence is limited, most studies having small
sample sizes and restricted populations. [7-10]
We analysed data from the Trauma Audit & Research Net-
work (TARN), a large European trauma registry, to evalu-
ate the association between the size of IB and, mortality
and haematoma evacuation, in patients with TBI.
Methods
Sample
TARN was established in 1989 to benchmark and improve
hospital trauma care (using case fatality measures). Mem-
bership is voluntary and includes 60% of hospitals receiv-
ing trauma patients in England and Wales and some
hospitals in European centres. TARN has ethical approval
for research on anonymized data through the patient
information access group (PIAG3-04(E) 2006). The TARN
database contains no patient identifiers
Data are collected on patients who arrive at hospital alive
and meet any of the subsequent criteria:
- Death from injury at any point during admission
- stay in hospital for longer than 3 days
- require intensive or high dependency care
- require inter  hospital transfer for specialist care
Patients with isolated closed limb injuries are excluded, as
are patients over 65 years with isolated fracture neck of
femur or pubic ramus fracture. All other isolated closed
femoral injuries are included. The details of the data col-
lection process have been described in detail elsewhere.
Briefly, data are collated by trained staff in participating
hospitals and submitted via the TARN Electronic Data
Collection and Reporting (EDCR) system (ref http://
www.tarn.ac.uk). Each submission is checked for consist-
ency and accuracy by trained coders at the University of
Manchester. All injuries are coded using the Abbreviated
Injury Scale 1998 Dictionary which allocates each injury a
severity code between 1 (minimal) and 6 (maximal). [11]
AIS severity coding is derived from the precise injury
descriptions given by imaging, operative and post mortem
reports. Adult (age > 15 yrs at time of injury) patients pre-
senting between 2001 and 2008 to TARN participating
hospitals were included in the study dataset if they had a
Glasgow Coma Score (GCS) less than 15 at presentation
or any head injury with AIS severity code 3 and above.
Only cases with known final outcome were selected.
Variables
Main Exposure
The extent of intracranial bleeding was determined from
the AIS code. [11] IB was coded as epidural (EDH) sub-
dural (SDH) and intraparenchymal (IPH). Each type was
coded as absent, present small (AIS4), present large
(AIS5) or present size unspecified (AIS4), referred as "no
further specification" (NFS) in this paper. There are differ-
ences in the volume of blood that attract "small/large
(AIS4/5)" codes depending on the site of bleeding (Addi-
tional file 1). Subarachnoid haemorrhage (SAH) was
coded as present or absent. Data about the size of the hae-
matoma refer to the "worst" CT scan information availa-
ble.
Potential confounders of the relationship between size of
bleeding and patient outcome were selected for the multi-
variable analysis. These variables were: age, GCS, SAH,
brain contusions, brain swelling, petechial haemorrhages,
presence of other brain injuries (skull fractures and any
brain lesion no further specified), presence of extracranial
injuries (AIS with severity score >2), and whether or notBMC Emergency Medicine 2009, 9:15 http://www.biomedcentral.com/1471-227X/9/15
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the TBI patient has been treated at a neurosurgical unit
(NSU). These variables have previously been reported to
be associated with poor outcome. [4,12-14]
Other variables reported for descriptive purposes of the
sample were: gender, cause of injury (road traffic crash,
fall <2 m, fall > 2 m) and Injury Severity Score (ISS). ISS is
a summary of the overall severity of anatomical injury for
each patient. [15] It has an ordinal scale from 175 and is
derived from the AIS severity scores for each injury.
The main outcome was in hospital mortality. We also
explored the association between size of bleeding and
evacuation of haematoma.
Analysis
Deciding which variables should be considered con-
founders and which should be considered mediators that
are on the causal pathway between bleeding and outcome
requires a conceptual framework. We could consider as
confounders all variables shown to be associated with
poor prognosis in TBI, such as age, severity of the TBI (as
defined by GCS) and other CT scan abnormalities. How-
ever, some of these variables (e.g. brain swelling) might be
on the causal pathway between bleeding and patient out-
come, and others (e.g. GCS) might be a consequence of
intracranial bleeding, though not on the causal pathway.
Adjusting for these variables would attenuate a true asso-
ciation between bleeding and outcome. Because of the
uncertainty in determining which factors are confounders
and which are on the causal pathway, we analysed the
data from two conceptual frameworks, in the hope that
the two different analyses would provide a better under-
standing of the association between IB and outcome. The
first includes all potential confounders, the second,
excludes those variables that could be on the causal path-
way between IB and patient outcome. Each exposure and
confounding variable was entered into a multivariable
logistic regression analysis to analyse its relationship with
outcome. A first analysis considered no bleeding as the
baseline category and mortality and haematoma evacua-
tion as outcomes. Because we were interested in quantify-
ing the mortality risk associated with large, as opposed to
small IB, we also conducted a second analysis evaluating
the effect of IB size on mortality using small IB as the base-
line. To determine the functional form of the predictors
age and GCS in the model, fractional polynomials, quad-
ratic and cubic spline and Lowess smoothing were
explored.
Results
Between 2001 and 2008 15,754 adult patients meeting
study inclusion criteria for TBI presented to TARN hospi-
tals and were submitted. In 1792 patients, the GCS on
arrival at the first hospital was missing. The remaining
13,962 were used for this study.
Table 1 describe the characteristics of the study popula-
tion. Almost three quarters of the patients were male. The
median age was 41 years old, the median GCS was 13 and
the median ISS was 18. The commonest mechanism of
injury was road traffic crashes and in-hospital mortality
was 22%. A total of 6445 patients (46%) had some type
of IB (EPH, SDH, IPH or SAH). Of these patients 2,922
(45%) had one type of IB, 1018 (16%) had two types of
IB, 1619 (25%) had three types of IB and 886 (14%) had
four types IB.
Table 1: Demographics
All patients EDH haemorrhage SDH haemorrhage IPH haemorrhage SAH No bleeding
N 13962 (100%) 3140 (22.5%) 4204 (30.1%) 2990 (21.8%) 3025 (21.7%) 7517 (53.8%)
NFS 2,185 (70%) 1985 (47%) 2193 (73%)
Small NA 536 (17%) 1168 (28%) 321(11%) NA NA
Large 419 (13% 1051 (25%) 476 (16%)
Median Age 40.7 43.4 48.9 47.1 46.6 37.8
Male 10229 (73.3%) 2352 (74.9%) 3050 (72.5%) 2187 (73.1%) 2257 (74.6%) 5456 (72.6%)
Female 3733 (26.7%) 788 (25.1%) 1154 (27.5%) 803 (26.9%) 768 (25.4%) 2061 (27.4%)
Median GCS 13 11 10 11 8 14
Median ISS 18 25 25 25 25 13
RTC 6125 (43.9%) 1053 (33.5%) 1337 (31.8%) 1025 (34.3%) 1299 (42.9%) 3756 (50.0%)
Fall more > 2 m 2312 (16.6%) 753 (24.0%) 1026 (24.4%) 690 (23.1%) 715 (23.6%) 892 (11.9%)
Fall <2 m 2706 (19.4%) 720 (22.9%) 1119 (26.6%) 763 (25.5%) 561 (18.5%) 1238 (16.5%)
Other 2819 (20.2%) 614 (19.6%) 722 (17.2%) 512 (17.1%) 450 (14.9%) 1631 (21.7%)
Non NSU 7907 (56.6%) 1523 (48.5%) 2044 (48.6%) 1634 (54.6%) 1426 (47.1%) 4813 (64.0%)
NSU 6055 (43.4%) 1617 (51.5%) 2160 (51.4%) 1356 (45.4%) 1599 (52.9%) 2704 (36.0%)
Mortality 3065 (22.0%) 869 (27.7%) 1380 (32.8%) 950 (31.8%) 1222 (40.4%) 1098 (14.6%)
NFS: No further specified; GCS: Glasgow coma scale; ISS: Injury severity score; RTC: Road traffic collision; NSU: Neurosurgical unit; EDH: 
Extradural haematoma; SDH: Subdural Haematoma; IPH: Intracerebral HaemorrhageBMC Emergency Medicine 2009, 9:15 http://www.biomedcentral.com/1471-227X/9/15
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SDH was the most common type, present in 30% of the
patients. EDH, IPH and SAH were present in 22% each.
Among patients with IB, the size (either large or small)
was reported in 30% of those with EDH, in 53% with
SDH and in 27% of patients with IPH. Patients with IB
were in general older, with more severe TBI (as defined by
GCS) and had higher in-hospital mortality. Among the
different types of IB, patients with EDH were youngest,
and those with SAH had the highest in-hospital mortality.
Patients with IPH were less frequently hospitalized in
services with neurosurgery (NSU). Patients with missing
GCS, and therefore excluded, were similar to those
included in the analysis but there was a slightly larger pro-
portion of males (81% vs. 73%) with a higher median ISS
(25 vs.18).
Relationship between age and GCS with mortality
Figures 1 and 2 show the fit of the three functional forms
to the observed data. It can be seen that fractional polyno-
mials (FP) fit the data well for both Age and GCS, there-
fore they were included in this way in the analysis.
For Age the optimal functional form is the sum of square
root age and age, for GCS it is the sum of inverse GCS
cubed and GCS.
In-hospital Mortality
Table 2 shows the unadjusted and adjusted effect (odds
ratio) for mortality of the different types, and size, of IB.
Unadjusted analysis
IB either coded as large or as NFS in all locations were
associated with an increased risk of mortality in compari-
son with no bleeding. Large SDH and large IPH were asso-
ciated with a worse prognosis, with an odds ratio for
mortality of 6.30 (95%CI 5.507.21) and 4.19 (95% CI
3.465.06) respectively. Small SDH were the only small
lesions associated with an increase in mortality.
Adjusted analysis
There was strong evidence of an association with mortal-
ity for all the potential confounder variables (age, GCS,
presence of extracranial injury, treatment at a NSU, brain
contusion, brain swelling, petechial haemorrhages, SAH
and other brain injuries) so they were all included in the
multivariable model.
After adjustment for confounding variables, large IB irre-
spective of location was associated with an increased risk
of mortality. The odds ratio for large SDH was halved after
adjustment (3.36 95% CI: 2.764.08), the odds ratio for
large IPH was slightly attenuated (3.10 95% CI: 2.384.03)
and the association between large EDH and mortality
remained virtually unchanged (1.85 95% CI: 1.362.51).
After excluding GCS and brain swelling from the multivar-
iable analysis (model 2 in table 2), large IB remained the
only ones with a significant association with mortality,
with values that were more extreme than the odds ratio
reported in the fully adjusted models.
Evacuation of haematoma
Table 3 shows the unadjusted and adjusted effect (odds
ratio) for haematoma evacuation of the different types,
and size, of IB.
Unadjusted analysis
IB from all the locations and from all the categories (large,
small and NFS) were associated with an increased risk of
evacuation, except for small IPH. EDH and SDH showed
the largest odds ratio (22.6 and 13.7 respectively)
Adjusted analysis
After adjusting for all potential confounding variables,
there was an increased risk of haematoma evacuation for
both SDH and EDH. The magnitude of the association
was larger for large haematomas, intermediate for those
coded as NFS and smallest for the small ones. The odds
ratio for large EDH and SDH were, respectively, 25.58
(95% CI: 18.8034.81) and 15.47 (95% CI: 11.8820.13).
After multivariate analysis none of the categories of IPH
remained positively associated with evacuation. Similar
results were obtained when excluding GCS and brain
swelling from the multivariable adjustment.
Comparison between large and small haemorrhages
In table 4 it can be seen that large IB, wherever the loca-
tion, were associated with an increased risk of mortality,
in comparison with small IB lesions. After adjusting for
potential confounders (model 1) the odds ratio for mor-
tality was 2.86 (95% CI: 1.864.38) for large EDH, 3.41
(95% CI: 2.684.33) for large SDH and 3.47 (95% CI:
Functional form for Age Figure 1
Functional form for Age.
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Functional form for GCS Figure 2
Functional form for GCS.
3 5 7 9 11 13 15
Glasgow Coma score
P
r
o
b
a
b
i
l
i
t
y
 
o
f
 
d
e
a
t
h
 
(
l
o
g
i
t
 
s
c
a
l
e
)
Observed FP(-3 ; 1) Smoothing Cubic Spline
0.01
0.1
0.2
0.4
0.6
0.8
Table 2: Odds ratios (95% confidence intervals) for mortality according to haemorrhage size
Unadjusted  Adjusted model 1 † Adjusted model 2‡
No EDH 1 1 1
EDH haemorrhage NFS 1.77 (1.60 to 1.96) 1.28 (0.84  1.93) 1.27 (0.89  1.83)
Small 0.57 (0.43 to 0.74) 0.67 (0.47  0.95) 0.61 (0.45  0.83)
Large 1.61 (1.29 to 2.01) 1.85 (1.36  2.51) 2.11 (1.62  2.75)
No SDH 1 1 1
SDH haemorrhage NFS 1.75 (1.57 to 1.96) 0.98 (0.71  1.35) 1.05 (0.80  1.40)
Small 1.31 (1.13 to 1.53) 0.99 (0.81  1.22) 1.21 (1.02  1.44)
Large 6.30 (5.50 to 7.21) 3.36 (2.76  4.08) 7.09 (6.01  8.37)
No IPH 1 1 1
IPH haemorrhage NFS 1.79 (1.61 to 1.98) 1.13 (0.75  1.69) 1.40 (0.98  1.99)
Small 0.88 (0.65 to 1.19) 0.89 (0.61  1.30) 0.83 (0.60  1.15)
Large 4.19 (3.46 to 5.06) 3.10 (2.38  4.04) 3.45 (2.74  4.33)
Variables included in the model: † Age, GCS, NSU, EDH, SDH, IPH, Brain contusion, Swelling, Petechial, SAH, Other brain injuries, Extracranial 
injuries.
‡ Age, NSU, EDH, SDH, IPH, Brain contusion, Petechial, Penetrating, SAH, Other brain injuries, Extracranial injuries.BMC Emergency Medicine 2009, 9:15 http://www.biomedcentral.com/1471-227X/9/15
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2.265.33) for large IPH. Patients with EDH coded as NFS
had an odds ratio for mortality of 1.89 (95% CI:
1.202.99) in comparison with those with small EDH.
There was no strong evidence of increased risk of mortal-
ity for those patients with SDH or IPH coded as NFS when
compared with patients with the corresponding lesions
coded as small.
Discussion
This analysis of over 13,000 patients with TBI showed that
patients with a large EDH, SDH or IPH have a substan-
tially higher mortality than patients with either no bleed-
ing or a small bleed. Even after adjusting for other CT
findings, such as contusions and brain swelling, and other
potential confounding variables, such as age and GCS,
large bleeds substantially increased the probability of
death. Patients with large IPH or large SDH had more
than a threefold increased in mortality odds in compari-
son with patients with small IB in the same location,
while large EDH showed more than a doubling in the
mortality odds in comparison with patients with small
EDH. Small IB were not associated with an increased in
mortality after adjustment for other potentially confound-
ing variables. Patients with IB coded as NFS had generally
a risk which was intermediate between that reported for
patients with large and the one reported for patients with
small IB.
The frequency of IB after a TBI varies according to the
inclusion criteria of the different studies. The incidence of
IB in our analysis was higher than other series because of
the TARN inclusion criteria. TBI patients are included if
they die at any point during admission, stay in hospital
for longer than 3 days, require intensive or high depend-
ency care or require inter  hospital transfer for specialist
care. Studies that also included hospitalized TBI patients
reported similar frequencies of IB as the one we reported.
For example in the CRASH Trial which was the largest trial
conducted among TBI patients, 56% of the patients have
some type of IB and 27% presented a subarachnoid haem-
orrhage which is similar to the 22% incidence reported in
this study. [4] In the IMPACT study, which included 9 ran-
domised clinical trials in TBI patients, the range of fre-
quency for EPH and SDH was 720% and 2036%
respectively, which is similar to the frequency reported in
our study. [16] Our results are consistent, but more pre-
cise, than those of previous studies showing that IB is
associated with increased mortality. There has not been
any systematic review describing the association between
Table 3: Odds ratios (95% confidence intervals) for haematoma evacuation according to haemorrhage size
Unadjusted  Adjusted model 1† Adjusted model 2‡
No EDH 1 1 1
EDH hemorrhage NFS 4.69 (4.02 to 5.49) 2.78 (1.75  4.44) 2.95 (1.85  4.70)
Small 3.96 (2.98 to 5.20) 2.99 (2.15  4.20) 3.08 (2.22  4.27)
Large 22.56 (18.05 to 28.16) 25.58 (18.80  34.81) 28.87 (21.27  39.20)
No SDH 1 1 1
SDH hemorrhage NFS 6.43 (5.40 to 7.65) 5.58 (3.78  8.25) 5.77 (3.91  8.50)
Small 3.96 (3.14 to 4.98) 3.29 (2.50  4.33) 3.59 (2.73  4.72)
Large 13.70 (11.40 to 16.47) 15.47 (11.88  20.13) 19.40 (15.07  24.97)
No IPH 1 1 1
IPH hemorrhage NFS 3.54 (3.07 to 4.08) 0.58 0.36  0.95) 0.58 (0.36  0.95)
Small 0.82 (0.44 to 1.40) 0.617 (0.31  1.22) 0.66 (0.34  1.29)
Large 1.91 (1.36 to 2.63) 0.91 (0.57  1.44) 1.04 (0.66  1.63)
Variables included in the model: † Age, GCS, NSU, EDH, SDH, IPH, Brain contusion, Swelling, Petechial, SAH, Other brain injuries, Extracranial 
injuries.
‡ Age, NSU, EDH, SDH, IPH, Brain contusion, Petechial, Penetrating, SAH, Other brain injuries, Extracranial injuries.
Table 4: Odds ratios (95% confidence intervals) for mortality 
with small haemorrhages as baseline
Adjusted odds ratio †
Small 1
EDH haemorrhage No EDH 1.49 (1.05  2.12)
NFS 1.89 (1.20  2.99)
Large 2.86 (1.86  4.38)
Small 1
SDH haemorrhage No SDH 1.07 (0.85  1.35)
NFS 0.99 (0.72  1.37)
Large 3.41 (2.68  4.33)
Small 1
IPH haemorrhage No IPH 1.23 (0.84  1.80)
NFS 1.39 (0.84  2.28)
Large 3.47 (2.26  5.33)
Variables included in the model: † Age, GCS, NSU, EDH, SDH, IPH, 
Brain contusion, Swelling, Petechial,, SAH, Other brain, Extracranial 
injuries.BMC Emergency Medicine 2009, 9:15 http://www.biomedcentral.com/1471-227X/9/15
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size of IB and prognosis in TBI but a comprehensive
review has been reported in the Guideline for the Surgical
Management of Traumatic Brain Injury". [17] In this
guideline bleeding size is taken into account to recom-
mend surgical evacuation. However, the evidence pre-
sented in the guideline is very limited. For EDH the
guideline reported only seven studies that evaluated the
effect of size on outcome. The median of patients
included was 74 (range: 22200). In relation to SDH only
seven studies reported on the effect of size with a median
number of patients of 91 (range 23206). For IPH seven
studies were reported, with a median of 85 patients
included (range 23321). Furthermore in only a few stud-
ies mortality or disability were considered as outcomes
and, many of the studies included selected samples (e.g.
only surgical patients) and were retrospective analysis of
one centre database.
Our findings are also in keeping with the results of previ-
ous publications showing that SDH is associated with a
much larger increased in the probability of death than
EDH. [17]
We found that only large IB, wherever the location (EDH,
SDH or IPH) are associated with worse outcome and that
large IB are associated with an increased risk of death in
comparison with small IB. Further studies should also
evaluate the effect of size on disability using outcomes
such as the Glasgow Outcome Scale.
The strength of our analysis is that it included more than
13,000 patients with traumatic brain injury and so the
precision of our estimates of the risk associated with IB is
high. We also adjusted for most of the relevant potential
confounding variables.
An important limitation of this study is that in a large pro-
portion of patients it was not reported whether the IB was
small or large. These patients, with size coded as NFS, pre-
sented intermediate risk between patients with small and
large lesions. Another limitation is that we did not have
information on pupil reactivity which has been shown to
be an important prognostic factor. A further limitation is
that we had no continuous measurements of the size of
the bleeding, nor did we analyse on the timing of the CT
scan. Although 90% of patients were included in the anal-
ysis, some were excluded because of a lack of data on GCS.
Nevertheless, the characteristics of the excluded patients
were similar to those included, making bias unlikely.
Finally, size of bleeding is only one of the prognostic fac-
tors in patients with TBI and IB. In this study we were able
to consider some of other prognostic factors such as TBI
severity (GCS) and brain swelling, but other such as the
localization of the bleeding were not available and were
not included in this analysis. It is plausible that the effect
of IB will vary according to the localization, as the func-
tional outcome would be influenced by the brain region
affected,. Future studies should explore the different effect
on functional outcomes according to the localization of
the IB.
There is some evidence that bleeds could enlarge in the
2448 hours after injury. Oertel and colleagues studied
patients in whom two CT scans were obtained within 24
hours of injury to determine the prevalence of progressive
bleeding. [18] Among patients who had their first scan
within 2 hours of injury, 49% had radiological evidence
of progressive bleeding. Yadav and colleagues scanned TBI
patients at hospital admission and 24 hours later, and
found that 16% of 262 parenchymal haematomas and
contusions increased in size in the first 24 hours. [19]
Similarly, Sullivan et al found that traumatic epidural
haemorrhages enlarged in 23% of 160 TBI patients treated
non-operatively. [20] More recently Narayan and col-
leagues reported a study in which they included patients
with TBI and IPH confirmed by CT scan of = 2 ml. They
repeated the CT scan at 24 and 72 hours and found that in
51% of the included patients IPHs expand in the first 24
hours. Although these studies provide estimates of the
occurrence of intracranial bleeding and expansion they all
have limitations. All included patients who have an
abnormal initial CT scan and there is little information on
the proportion of patients that develop new intracranial
bleeds in the first 24 hours who have the potential to ben-
efit from early treatment. Further studies are needed to
clarify the timing of IB expansion. A large cohort of TBI
patients with an early CT scan and a second CT scan
within 2448 hours including patients with a range of TBI
severity is needed to clarify the natural history and prog-
nostic role of traumatic progressive IB.
Conclusion
In conclusion in this analysis we found an association
between size of intracranial bleeding and mortality in TBI
patients. However, the limitation of our data, such as the
large proportion of missing data and lack of data on other
confounding factors such as localization of the bleeding
make the results of this report only explanatory. Further-
more we were only able to evaluate the effect of IB in mor-
tality. Future studies with more complete data should
confirm or refute our results and also evaluate the effect of
IB size on functional outcomes
Finally the effect on mortality of interventions that reduce
the extent of intracranial bleeding would only be able to
establish through prospective randomised controlled tri-
als.
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